UNION therapeutics A/S

As development continues on orismilast, which UNION therapeutics A/S believes will prove superior to Amgen, Inc. 's psoriasis drug Otezla, the Danish company has inked a potentially lucrative licen

Moderna’s Variant-Targeting Vaccine Moves Into Clinical Trial Moderna is demonstrating the speed of its mRNA vaccine development process once again, announcing that an updated version of its vaccine

In two initiatives intended to increase the transparency of its coronavirus activities, the European Medicines Agency has published the clinical data that was used to support the EU marketing authoriz

BioNTech, Fosun Dose First Participants In China Phase I Trial With BNT162b1 BioNTech SE and partner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have dosed the first 72 participants in a Phase